GMMMG and its subgroups consist of GPs, pharmacists and other key healthcare professionals. We seek to identify and champion the appropriate use of medicines across Greater Manchester taking into account cost effectiveness, quality, equity and patient safety. The group is formally accountable to the GM Clinical Effectiveness and Governance Committee of the ICB, and the work plan is facilitated and supported by the Regional Drug & Therapeutics Centre in Newcastle and the Greater Manchester ICS.
To contact the professional secretary of GMMMG or any of its subgroups, please email firstname.lastname@example.org.
|Document Title||Issue Date||Review Date||Status|
|GMMMG Medicines Optimisation Committee terms of reference||20230126 Jan 2023||Approved|
|GMMMG members roles and responsibilities||20230126 Jan 2023||Approved|
|GMMMG Charter||20220926 Sep 2022||Approved|
|GMMMG Clinical Reference Group terms of reference||20230126 Jan 2023||Approved|
|Digital workstream group terms of reference||20230126 Jan 2023||Approved|
|Medicines Safety workstream group terms of reference||20230126 Jan 2023||Approved|
|Medicines Value workstream group||20230926 Sep 2023||Approved|
|Population Health Management and Health Inequalities workstream group terms of reference||20230126 Jan 2023||Approved|
|Workforce group terms of reference||20230226 Feb 2023||Approved|